CTS CTS CORP

NYSE ctscorp.com


$ 40.48 $ -1.93 (-4.55 %)    

Tuesday, 28-Oct-2025 15:59:53 EDT
QQQ $ 633.55 $ 4.83 (0.77 %)
DIA $ 476.83 $ 1.80 (0.38 %)
SPY $ 687.33 $ 1.82 (0.27 %)
TLT $ 92.10 $ 0.24 (0.26 %)
GLD $ 364.95 $ -2.63 (-0.72 %)
$ 40.51
$ 42.67
$ 36.22 x 1
$ 45.00 x 25
$ 36.21 - $ 42.67
$ 33.95 - $ 59.47
394,006
na
1.18B
$ 0.92
$ 19.69
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 10-28-2025 09-30-2025 10-Q
2 07-24-2025 06-30-2025 10-Q
3 04-30-2025 03-31-2025 10-Q
4 02-26-2025 01-01-1970 10-K
5 10-29-2024 09-30-2024 10-Q
6 07-30-2024 06-30-2024 10-Q
7 05-01-2024 03-31-2024 10-Q
8 02-23-2024 12-31-2023 10-K
9 10-26-2023 09-30-2023 10-Q
10 07-25-2023 06-30-2023 10-Q
11 04-27-2023 03-31-2023 10-Q
12 02-24-2023 12-31-2022 10-K
13 10-26-2022 09-30-2022 10-Q
14 07-26-2022 06-30-2022 10-Q
15 04-28-2022 03-31-2022 10-Q
16 02-25-2022 12-31-2021 10-K
17 10-27-2021 09-30-2021 10-Q
18 07-27-2021 06-30-2021 10-Q
19 04-29-2021 03-31-2021 10-Q
20 02-25-2021 12-31-2020 10-K
21 10-29-2020 09-30-2020 10-Q
22 07-31-2020 06-30-2020 10-Q
23 04-24-2020 03-31-2020 10-Q
24 02-20-2020 12-31-2019 10-K
25 10-24-2019 09-30-2019 10-Q
26 07-25-2019 06-30-2019 10-Q
27 04-25-2019 03-31-2019 10-Q
28 02-22-2019 12-31-2018 10-K
29 10-25-2018 09-30-2018 10-Q
30 07-26-2018 06-30-2018 10-Q
31 04-26-2018 03-31-2018 10-Q
32 02-23-2018 12-31-2017 10-K
33 10-26-2017 09-30-2017 10-Q
34 07-27-2017 06-30-2017 10-Q
35 04-27-2017 03-31-2017 10-Q
36 02-24-2017 12-31-2016 10-K
37 10-28-2016 09-30-2016 10-Q
38 07-29-2016 06-30-2016 10-Q
39 05-03-2016 03-31-2016 10-Q
40 02-24-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 cts-narrows-fy2025-adj-eps-guidance-from-220-235-to-220-225-vs-224-est-narrows-fy2025-sales-guidance-from-520000m-550000m-to-535000m-545000m-vs-530600m-est

CTS (NYSE:CTS) narrows FY2025 Adj EPS guidance from $2.20-$2.35 to $2.20-$2.25 vs $2.24 analyst estimate. Narrows FY2025 sales ...

 cts-q3-adj-eps-060-misses-061-estimate-sales-142970m-beat-136397m-estimate

CTS (NYSE:CTS) reported quarterly earnings of $0.60 per share which missed the analyst consensus estimate of $0.61 by 1.64 perc...

 cts-affirms-fy2025-adj-eps-guidance-of-220-235-vs-220-est-affirms-fy2025-sales-guidance-of-52000m-55000m-vs-53320m-est

CTS (NYSE:CTS) affirms FY2025 Adj EPS guidance from $2.20-$2.35 to $2.20-$2.35 vs $2.20 analyst estimate. Affirms FY2025 sales ...

 cts-q2-adj-eps-057-beats-055-estimate-sales-13531m-beat-13265m-estimate

CTS (NYSE:CTS) reported quarterly earnings of $0.57 per share which beat the analyst consensus estimate of $0.55 by 3.64 percen...

 cts-q1-adj-eps-044-misses-049-estimate-sales-12577m-miss-12872m-estimate

CTS (NYSE:CTS) reported quarterly earnings of $0.44 per share which missed the analyst consensus estimate of $0.49 by 10.2 perc...

 cts-earnings-analysis-q4-recap
CTS Earnings Analysis: Q4 Recap
02/04/2025 13:35:28

 cts-q4-2024-adj-eps-053-misses-059-estimate-sales-127435m-miss-132804m-estimate

CTS (NYSE:CTS) reported quarterly earnings of $0.53 per share which missed the analyst consensus estimate of $0.59 by 10.17 per...

 cts-q3-2024-adj-eps-063-beats-057-estimate-sales-132424m-miss-132479m-estimate

CTS (NYSE:CTS) reported quarterly earnings of $0.63 per share which beat the analyst consensus estimate of $0.57 by 10.53 perce...

 cts-q2-earnings-assessment
CTS Q2 Earnings Assessment
08/08/2024 12:43:01

 cts-corporation-sees-fy24-adjusted-diluted-eps-to-be-in-range-of-205-225-vs-224-est-prior-view-210-235

Given the more moderate growth expectations in the second half of 2024, CTS is updating its guidance for full year 2024 sales t...

 cts-q2-adj-054-beats-053-estimate-sales-13016m-miss-13338m-estimate

CTS (NYSE:CTS) reported quarterly earnings of $0.54 per share which beat the analyst consensus estimate of $0.53 by 1.89 percen...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION